References

  1. Mariotti A. A primer on inflammation. Compend Cont Educ Dent 2004; 25 (7) (Suppl 1):7-15.
  2. Kornman KS, Page RC, Tonetti MS. The host response to the microbial challenge in periodontitis: assembling the players. Periodontol 2000 1997; 14:33-53.
  3. Armitage GC. Diagnosis of periodontal diseases. J Periodontol 2003; 74; 1237-47.
  4. Scannapieco FA: Periodontal inflammation: from gingivitis to systemic disease? Compend Cont Educ Dent 2004; 25 (7) (Suppl 1): 16-25.
  5. Ebersole JL, Machen RL, Steffen MJ, et al. Systemic acute-phase reactants, C-reactive protein and haptoglobin, in adult periodontitis. Clin Exp Immunol 1997; 107: 347-52.
  6. Loos BG, Craandijk J, Hoek FL, et al. Elevation of systemic markers related to cardiovascular disease in the peripheral blood of periodontitis patients. J Periodontol 2000; 71: 1528-34.
  7. Danesh J, Collins R, Appleby P, et al. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. J Am Med Assoc. 1998; 279: 1477-82.
  8. Ridker PM, Buring JE, Shih J, et al. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation. 1998;98:731-33.
  9. D’Aiuto F, Parkar M, Andreou G, et al. Periodontitis and systemic inflammation: control of the local infection is associated with a reduction in serum inflammatory markers. J Dent Res 2004; 83:156-60.
  10. Schwartz CJ, Valente AJ, Sprague EA, et al. The pathogenesis of atherosclerosis: an overview. Clin Cardiol 1991; 14 (2 suppl 1): 11-6.
  11. Paigen B, Morrow A, Holmes PA, et al. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 1987; 68: 231-40.
  12. Ridker PM, Hennekens CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342: 836-43.
  13. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994; 331: 417-24.
  14. Ruderman NB, Williamson JR, Brownlee M. Glucose and diabetic vascular disease. FASEB J. 1992; 6: 2905-14.
  15. Bhakdi S, Torzewski M, Klouche M, et al. Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol. 1999; 19: 2348-54.
  16. Zwaka TP, Hombach V, Torzewski J. C-reactive protrein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 2001; 103: 1194-7.
  17. Epstein SE. The multiple mechanisms by which infection may contribute to atherosclerosis development and course. Circ Res 2002; 90: 2-4.
  18. Haraszthy VI, Zambon JJ, Trevisan M, et al. Identification of periodontal pathogens in atheromatous plaques. J Periodontol. 2000; 71 (10): 1554-60.
  19. Herzberg MC, Meyer MW: Effects of oral flora on platelets: possible consequences in cardiovascular disease. J Periodontol. 1996; 67 (10Suppl): 1138-42.
  20. Paquette DW. The periodontal-cardiovascular link. Compend Cont Educ Dent. 2004; 25 (9):681-92.
  21. Desvarieux M, Demmer RT, Rundek T, et al. Periodontal microbiota and carotid intima-media thickness: the oral infections and vascular disease epidemiology study (INVEST). Circulation. 2005; 111 (5): 576-82.
  22. Löe H. Periodontal disease. The sixth complication of diabetes mellitus. Diabetes Care. 1993; 16: 329-34.
  23. Nishimura F, Takahshi K, Kurihara M, et al. Periodontal disease as a complication of diabetes mellitus. Ann Periodontol. 1998;3:20-29.
  24. Ryan ME, Carnu A, Kamer A. The influence of diabetes on the periodontal tissues. J Am Dent Assoc 2003; 134: 34S-40S.
  25. Taylor GW, Burt BA, Becker MP, et al. Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol 1996; 67 (10 Suppl): 1085-93.
  26. Grossi SG, Skrepcinski FB, DeCaro T, et al. Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol 1997; 68: 713-9.
  27. Miller LS, Manwell MA, Newbold D, et al. The relationship between reduction in periodontal inflammation and diabetes control: a report of 9 cases. J Periodontol 1992; 63: 843-8.
  28. Mealey DL, Rethman MP: Periodontal disease and diabetes mellitus. Bidirectional relationship. Dent Today 2003; 22: 107-13.
  29. Ryan ME, Ramamurthy NS, Corsa T, Golub LM. MMP-mediated events in diabetes. Ann NY Acad Sci 1999; 878: 331-4.
  30. Ryan ME, Usman A, Ramamurthy NS, et al. Excessive matrix metalloproteinase activity in diabetes: inhibition by tetracycline analogues with zinc reactivity. Curr Med Chem 2001; 8 (3): 305-16.
  31. Salvi GE, Yalda B, Collins JG, et al. Inflammatory mediator response as a potential risk marker for periodontal diseases in insulin-dependent diabetes mellitus patients. J Periodontol 1997; 68: 127-35.
  32. Lalla E, Lamster IB, Feit M, et al. Blockade of RAGE suppresses periodontitis-associated bone loss in diabetic mice. J Clin Invest 2000; 105: 1117-24.
  33. Grossi SG, Genco RJ. Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol 1998; 3: 51-61.
  34. Graves DT, Al-Mashat H, Liu, RL. Evidence that diabetes mellitus aggravates periodontal diseases and modifies the response to an oral pathogen in animal models. Compend Cont Educ Dent. 2004; 25 (7) (Suppl 1): 38-45.
  35. Scannapieco FA. Role of oral bacteria in respiratory infection. J Periodontol. 1999; 70: 793-802.
  36. Scannapieco FA, Bush RM, Paju S. Associations between periodontal disease and risk for nosocomial bacterial pneumonia and chronic obstructive pulmonary disease: a systematic review. Ann Periodontol. 2003; 8: 54-69.
  37. Hayes C, Sparrow D, Cohen M, et al. The association between alveolar bone loss and pulmonary function: the VA Dental Longitudinal Study. Ann Periodontol. 1998; 3: 257-61.
  38. Scannapieco FA, Ho AW. Potential associations between chronic respiratory disease and periodontal disease: analysis of National Health and Nutrition Examination Survey III. J Periodontol. 2001; 72: 50-6.
  39. Offenbacher S, Katz V, Fertik G, et al. Periodontal infection as a possible risk factor for preterm low birth weight. J Periodontol. 1996; 67 (10 suppl): 1103-13.
  40. Jeffcoat MK, Guers NC, Reddy MS, et al. Periodontal infection and preterm birth: results of a prospective study. J Am Dent Assoc. 2001; 132: 875-80.
  41. Scannapieco FA, Bush RP, Paju S. Periodontal disease as a risk factor for adverse pregnancy outcomes. A systematic review. Ann Periodontol 2003; 8: 70-8.
  42. Han YW, Redline RW, Li M, et al. Fusobacterium nucleatum induces premature and term stillbirth in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun. 2004; 72: 2272-9.
  43. Panagakos FS. Inflammation: its role in health and its mediation by chemotherapeutic agents. Continuing Education for the Healthcare Professional (CEHP), distributed by Sullivan-Schein, a Henry Schein Company, course reference #05AS2906B, 2005.
  44. Gurenlian JR. Diabetes mellitus: strategies for providing comprehensive care. Continuing Education for the Healthcare Professional (CEHP), distributed by Sullivan-Schein, a Henry Schein Company, course reference # 05AS2904, 2005.
  45. Gaffar A, Scherl D, Afflitto J, Coleman EJ. The effect of triclosan on mediators of gingival inflammation. J Clin Periodontol. 1995; 22(6): 480-4.
  46. Xu T, Deshmukh M, Barnes VM, et al. Effectiveness of a triclosan/copolymer dentifrice on microbiological and inflammatory parameters. Compend Cont Educ Dent 2004; 25 (7) (Suppl 1): 46-53.
  47. DeVizio W, Davies R. Rationale for the daily use of a dentifrice containing triclosan in the maintenance of oral health. Compend Cont Educ Dent 2004; 25 (7) (Suppl 1): 54-7.
ŠADHA 2006